Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma
Royal Marsden NHS Foundation Trust
Royal Marsden NHS Foundation Trust
Royal Marsden NHS Foundation Trust
Institut Bergonié
Swiss Cancer Institute
National Taiwan University Hospital
PharmaMar
ImmunoGenesis
Intensity Therapeutics, Inc.
Cyteir Therapeutics, Inc.
University Hospital, Antwerp
Moleculin Biotech, Inc.
Grupo Espanol de Investigacion en Sarcomas
Fred Hutchinson Cancer Center
University of Iowa
Hutchmed
TransThera Sciences (Nanjing), Inc.
Sierra Oncology LLC - a GSK company
Ludwig Institute for Cancer Research
University of Pittsburgh
Eisai Inc.
Royal Marsden NHS Foundation Trust
Novartis
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Tracon Pharmaceuticals Inc.
Clinica Universidad de Navarra, Universidad de Navarra
University Medical Center Groningen
Celgene
Fuda Cancer Hospital, Guangzhou
Sarcoma Alliance for Research through Collaboration
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Celldex Therapeutics
University of Vermont
Grupo Espanol de Investigacion en Sarcomas
Valerio Therapeutics
National Cancer Institute (NCI)
University of Helsinki
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
University of Kentucky
University of California, Davis
AGO Study Group
Epeius Biotechnologies
NYU Langone Health
Fred Hutchinson Cancer Center